Primary CNS Tumors
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations (NCT04094610) | Turning Point Therapeutics, Inc. | 2020-03-12 |
| A Study of TAS-120 in Patients With Advanced Solid Tumors (NCT02052778) | Taiho Oncology, Inc. | 2014-07-21 |
Track Primary CNS Tumors automatically
Every clearance here is in the API, with alerts when new ones post.